Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
January 06, 2011
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
BD Diagnostics seeks 510(k) approval for HSV 1 and II assays; Celera submits premarket approval application for KIF6 Genotyping Assay; Cepheid launches Xpert Flu as CE IVD Marked test in Europe.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Cepheid Reports Q4, FY '12 Revenue Growth, but Looks to Address Issues from 'Challenging' Year
January 31, 2013 / PCR Insider - Dx Focus: Cepheid Xpert CT/NG; AITbiotech abTES Flu 4-Plex and MTB Real-Time Assays
January 3, 2013 / PCR Insider - Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 6, 2012 / PCR Insider